Takeuchi Hideyuki, Haltiwanger Robert S
Department of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY 11794-5215, USA.
Department of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY 11794-5215, USA.
Biochem Biophys Res Commun. 2014 Oct 17;453(2):235-42. doi: 10.1016/j.bbrc.2014.05.115. Epub 2014 Jun 6.
Notch signaling is essential for cell-fate specification in metazoans, and dysregulation of the pathway leads to a variety of human diseases including heart and vascular defects as well as cancer. Glycosylation of the Notch extracellular domain has emerged as an elegant means for regulating Notch activity, especially since the discovery that Fringe is a glycosyltransferase that modifies O-fucose in 2000. Since then, several other O-glycans on the extracellular domain have been demonstrated to modulate Notch activity. Here we will describe recent results on the molecular mechanisms by which Fringe modulates Notch activity, summarize recent work on how O-glucose, O-GlcNAc, and O-GalNAc glycans affect Notch, and discuss several human genetic disorders resulting from defects in Notch glycosylation.
Notch信号通路对于后生动物的细胞命运决定至关重要,该信号通路失调会导致多种人类疾病,包括心脏和血管缺陷以及癌症。Notch细胞外结构域的糖基化已成为调节Notch活性的一种精妙方式,特别是自2000年发现Fringe是一种修饰O-岩藻糖的糖基转移酶以来。从那时起,已证明细胞外结构域上的其他几种O-聚糖也能调节Notch活性。在此,我们将描述Fringe调节Notch活性的分子机制的最新研究结果,总结关于O-葡萄糖、O-GlcNAc和O-GalNAc聚糖如何影响Notch的近期工作,并讨论由Notch糖基化缺陷导致的几种人类遗传疾病。